logo
#

Latest news with #SchoolofBiotechnology

Delhi: JNU's MSc Biotech programme gets flexible exit, entry options
Delhi: JNU's MSc Biotech programme gets flexible exit, entry options

Hindustan Times

time20-06-2025

  • Science
  • Hindustan Times

Delhi: JNU's MSc Biotech programme gets flexible exit, entry options

The School of Biotechnology (SBT) at Jawaharlal Nehru University (JNU) is introducing multiple level entry and exit options for their MSc Biotechnology programme from the academic session 2025-26, the first round of admissions of which is ongoing. This comes as an effort to align the programme with the framework of the National Education Policy (NEP) 2020. JNU. (PTI) Under the new framework, students who complete one year of the two-year master's course will be awarded with a Postgraduate Diploma in Biotechnology and students who complete two years will get a postgraduate degree, the dean of SBT, Balaji (goes by first name), said on Friday. 'Students will not be applying separately for the diploma. Instead, those who complete the first year of the program can choose to exit after the second semester with the diploma, provided they meet all academic requirements and inform the department in advance,' Balaji told HT on Friday. He added, 'In addition to this, a new one-year (Research) program is now being offered as a lateral entry option. This flexible program is open to students who have either completed the first year of an in Biotechnology at another institute or finished a four-year undergraduate degree with a research component.' However, Balaji clarified that the admission to this programme depends on seat availability from the regular two-year course. 'We have a total of 30 seats available in the MSc programme as of now. So if 24 seats have been filled in the first year and we have seven seats left, then those seats will be offered in lateral entry in the second year,' he clarified. The second year will focus less on theory and more on research, as students will engage in full-time, year-long research project, working closely with faculty on contemporary problems in biotechnology and allied areas. 'To foster critical thinking and discussion, the program includes a vibrant Journal Club, where students analyze recent scientific papers and engage in peer debate, an experience that builds scientific literacy, public speaking, and analytical skills,' Balaji said. Registration for the first round of admission to SBT is scheduled to end on June 26.

Week-long GAIN course on models, algorithms for omics data analysis at BHU
Week-long GAIN course on models, algorithms for omics data analysis at BHU

Time of India

time10-06-2025

  • Science
  • Time of India

Week-long GAIN course on models, algorithms for omics data analysis at BHU

Varanasi: A week-long GIAN course on Models and Algorithms For Omics Data Analysis was organised by the School of Biotechnology, Institute of Science, BHU from June 2 to 6 under the Ministry of Education's initiative of Global Initiative of Academic Networks (GIAN). The initiative aims to enhance the country's existing academic resources, accelerate the pace of quality improvement, and elevate India's scientific and technological capability to global excellence. Prof Rajeev Kumar Azad from the Department of Biological Sciences at the University of North Texas, USA, shared his expert inputs during the course. tnn

Procurement rules for scientific research eased
Procurement rules for scientific research eased

Time of India

time07-06-2025

  • Business
  • Time of India

Procurement rules for scientific research eased

Mumbai: In a resounding shift, the ministry of finance eased a long-standing bottleneck in procurement rules that once tethered researchers to the govt e-Marketplace (GeM), now allowing them to source scientific equipment and consumables from outside it. The revision in monetary ceilings and procurement channels, officials say, required the direct intervention of Prime Minister Narendra Modi. For the scientific community, this isn't just administrative reform—it's an acknowledgment and a huge relief. "Science cannot be caged in platforms and progress cannot always be L1," said a frustrated scientist, who said procurement was running into long delays because of cost and quality issues. The spirit behind GeM portal is, in principle, noble, said most scientists—designed to uplift Indian suppliers and foster a self-reliant manufacturing ecosystem. "But behind the digital veneer of transparency and procurement lies a troubling reality." "As a scientist, I ask—what truly serves the nation? If I want to order a computer that serves my requirements today, I cannot buy one unless it is L1," said professor at the School of Biotechnology at Jawaharlal Nehru University, Binay Panda. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Most Successful Way of Intraday Trading is "Market Profile" TradeWise Learn More Undo Five amendments have been made to existing procurement rules. Vice-Chancellors and directors of India's top scientific and academic institutions no longer have to wait for clearances to procure scientific equipment and consumables for research. Under the newly eased rules, they now hold the power to approve Global Tender Enquiries—up to a staggering Rs 200 crore—if they believe the need is justified. No central nod, no extra scrutiny. Just their judgment. Similarly, the ceiling for direct purchases—those made without quotations—has been raised from Rs 1 lakh to Rs 2 lakh. And what once required a drawn-out trail of tenders—purchases from Rs 1 to 10 lakh—can now be cleared by a purchase committee for anything up to Rs 25 lakh. Additionally, the limits on limited tender enquiry have been lifted—from Rs 50 lakh to Rs 1 crore. And perhaps, most telling of all, said scientists—the need for open tenders—earlier triggered at Rs 50 lakh—will now apply only to purchases above Rs 1 crore. Minister of State for Science and Technology, Jitendra Singh, took to social media and termed this as "a landmark step" for enabling #EaseOfDoingResearch. "This will reduce delays, also enhance autonomy and flexibility for research institutions—empowering them to innovate faster," he added. Secretary of the Department of Science and Technology, Prof Abhay Karandikar, said, "It was made possible by the collective efforts of everyone, including other scientific secretaries, PSA, Department of Expenditure and Cabinet Secretariat. " Another scientist explained that in this "algorithm-driven marketplace, the lowest bidder always wins, never mind if the product fails the test of quality. What use is cost-efficiency if it sacrifices precision and most importantly, the requirements of a scientific experiment? What use is patriotism if it's only glued on?" "They don't really make these products here," added Prof Panda. "They import many parts, assemble them locally, and slap on a Make in India sticker—as if that alone sanctifies the machine." He quickly added, "If there is a good Indian product, we do not think twice. We prefer make-in-India by default—it's more affordable, support is better, and it's close by." Most scientists echoed this. However, "We don't want to buy an Indian product if science suffers. "

MKU prof to receive TN scientist award in biological sciences
MKU prof to receive TN scientist award in biological sciences

Time of India

time06-06-2025

  • Health
  • Time of India

MKU prof to receive TN scientist award in biological sciences

Madurai: An associate professor in the Department of Molecular Microbiology at the School of Biotechnology at Madurai Kamaraj University, Varalakshmi Perumal, has been selected for the Tamil Nadu Scientist Award (TANSA) 2023 by the Tamil Nadu State Council for Science and Technology in the discipline of Biological Sciences. According to a statement, Varalakshmi's primary research interests focus on exploring algal metabolites for therapeutic and bioenergy applications. For the past decade, her major research thrust at MKU was on 'Unveiling bioactive metabolites of underexplored algae and their associated bacteria from the coastal regions of South India', particularly investigating their potential against non-communicable diseases (NCDs). While current treatments for NCDs largely rely on bioactive molecules derived from terrestrial plants, marine sources remain largely untapped. This has driven her search for multimodal-acting compounds from marine macroalgae, especially brown algae, which are rich in complex bioactive metabolites such as phlorotannins with strong pharmacological potential. So far, Varalakshmi characterised more than 10 novel compounds from marine algae with therapeutic potential against diabetes, obesity, epilepsy, and cervical cancer. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store